Home Merck committed to Cubist after patent losses
 

Keywords :   


Merck committed to Cubist after patent losses

2014-12-09 19:25:55| Biotech - Topix.net

Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the patents protecting the company's top-selling antibiotic just hours after that deal was announced Monday. Shares of both companies tumbled Tuesday morning in the first day of trading after Cubist said a federal court invalidated four patents protecting Cubicin.

Tags: committed patent losses merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11 (CFI-ZCT1J02)
27.11
27.11QUICKSILVER 8/S 130
27.11
27.11Laurene LaVallis Key To Our Love 7 US
27.11THE SCOPE AFTER DARK LP
27.11
27.11DVD
More »